SEC Form 4 · accession 0001225208-18-006211
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J. Ballinger
Officer — EVP & Pres, Interven Cardio
Period of report
Mar 14, 2018
Accepted (ET)
Mar 15, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 14, 2018 | M | 9,375 | $6.28 | A | 113,954 | D | |
| Common StockF3,F2 | Mar 14, 2018 | S | 9,375 | $28.3718 | D | 104,579 | D | |
| Common StockF4,F2 | Mar 14, 2018 | S | 33,428 | $28.3097 | D | 71,151 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $6.28 | Mar 14, 2018 | M | 9,375 | D | — | Feb 27, 2022 | Common Stock | 9,375 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.27 to $28.51, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $28.51, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.